NewAmsterdam Pharma Co. NV (NAMS)
NewAmsterdam Pharma Market Cap: 4.038B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| uniQure NV | 1.255B |
| ProQR Therapeutics NV | 234.92M |
| Merus NV | 7.339B |
| argenx SE | 54.80B |
| Pharming Group NV | 1.198B |
Market Cap Related Metrics
| PS Ratio | 113.85 |
| PEG Ratio | -2.693 |
| Price to Book Value | 5.546 |
| Price | 35.61 |
| Earnings Yield | -5.73% |
| PEGY Ratio | -2.693 |